Novel in vivo method for measuring cholesterol mass flux in peripheral macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 12, 2011, Pages 2865-2871

  Weibel, Ginny L ^a   Hayes, Sara ^a   Wilson, Aisha ^b   Phillips, Michael C ^a   Billheimer, Jeffrey ^b   Rader, Daniel J ^b   Rothblat, George H ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

atherosclerosis; lipids; lipoproteins; macrophages; reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; CELL PROTEIN; CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; HOLLOW FIBER; HOLLOW FIBER CHOLESTEROL MASS FLUX ASSAY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHOLESTEROL; CYTOLOGICAL TECHNIQUES; FOAM CELLS; LIVER; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; PLAQUE, ATHEROSCLEROTIC;

EID: 81755173547     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.236406     Document Type: Article

References (21)

1. Glomset JA. The plasma lecithin:Cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-167.
2. Rothblat GH, Phillips MC. High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Current Opinion in Lipidology. 2010;21:229-238.
3. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. American Journal of Medicine. 1984;76:4-12. (Pubitemid 14151605)
4. Zhang YZ, Zanotti I, Reilly M, Glick JM, Rothblat GH, Rader DJ. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation. 2003;108: 661-663. (Pubitemid 36999247)
5. Wang MD, Kiss RS, Franklin V, McBride HM, Whitman SC, Marcel Y. Different cellular traffic of LDL-cholesterol and acetylated ldl-cholesterol leads to distinct reverse cholesterol transport pathways. J LipidRes. 2007; 48:633-645. (Pubitemid 46397466)
6. Samyn H, Moerland M, Van Gent T, Van Haperen R, Grosveld F, Van Tol A, de Crom R. Elevation of systemic pltp, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice. Atherosclerosis. 2009;204:429-434.
7. Nijstad N, Tolle T, de Boer JF, Buijs RV, Heeringa P, Van der Giet M, Tietge UJ. Myeloperoxidase and serum amyloid a contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase a(2). J Lipid Res. 2010;51: 743-754.
8. Naik SU, Wang X, da Silva JR, Jaye M, Macphee CH, Reilly MP, Billheimer JT, Rothblat GH, Rader DJ. Pharmacological activation of liver x receptors promotes reverse cholesterol transport in vivo. Circulation. 2006;113:90-97. (Pubitemid 43958493)
9. Wang X, Collins HL, Ranalletta M, Fuki IV, Billheimer JT, Rothblat GH, Tall AR, Rader DJ. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J ClinInvest. 2007;117:2216-2224. (Pubitemid 47219566)
10. Hatch FT, Lees RS. Practical methods for plasma lipoprotein analysis. AdvLipid Res. 1968;6:1-68.
11. Basu SK, Goldstein JL, Anderson RGW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA. 1976;73:3178-3182.
12. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme a cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem. 1995; 270:5772-5778.
13. Klansek J, Yancey P, St. Clair RW, Fischer RT, Johnson WJ, Glick JM. Cholesterol quantitation by GLC: Artifactual formation of short-chain steryl esters. J Lipid Res. 1995;36:2261-2266.
14. Markwell MAK, Haas SM, Bieber LL, Tolbert NE. A modification of the lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87:206-210. (Pubitemid 9050428)
15. Stein O, Dabach Y, Hollander G, Ben-Naim M, Halperin G, Stein Y. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis? Atherosclerosis. 1999;144:367-374. (Pubitemid 29305470)
16. Li AC, Binder CJ, Guiterrez A, Brown KK, Plotkin CR, Pattison JL, Valledor AF, Davis RA, Wilson TM, Witztum JL, Palinski W, Glass CK. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by pparand̈. J Clinical Invest. 2004;114: 1564-1576. (Pubitemid 40385547)
17. Bernard DW, Rodriguez A, Rothblat GH, Glick JM. Camp stimulates cholesteryl ester clearance to high density lipoproteins in J774 macrophages. J Biol Chem. 1991;266:710-716. (Pubitemid 21907172)
18. Brown MS, Goldstein JL, Krieger M, Ho YK, Anderson RGW. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J Cell Biol. 1979;82:597-613. (Pubitemid 10222832)
19. Rothblat GH, de la Llera-Moya M, Favari E, Yancey PG, Kellner-Weibel G. Cellular cholesterol flux studies: Methodological considerations. Atherosclerosis. 2002;163:1-8. (Pubitemid 34615720)
20. Sankaranarayanan S, de la Llera-Moya M, Drazul-Schrader D, Asztalos BF, Weibel GL, Rothblat GH. Importance of macrophage cholesterol content on the flux of cholesterol mass. J Lipid Res. 2010;51:3243-3249.
21. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331-340. (Pubitemid 27220877)